Danaher Corp (DHR)
272.83
-3.60
(-1.30%)
USD |
NYSE |
Sep 20, 16:00
272.62
-0.21
(-0.08%)
After-Hours: 19:52
Danaher Research and Development Expense (Quarterly): 391.00M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 391.00M |
March 31, 2024 | 368.00M |
December 31, 2023 | 239.00M |
September 30, 2023 | 417.00M |
June 30, 2023 | 361.00M |
March 31, 2023 | 373.00M |
December 31, 2022 | 236.00M |
September 30, 2022 | 420.00M |
June 30, 2022 | 431.00M |
March 31, 2022 | 441.00M |
December 31, 2021 | 251.00M |
September 30, 2021 | 441.00M |
June 30, 2021 | 426.00M |
March 31, 2021 | 380.00M |
December 31, 2020 | 396.00M |
September 30, 2020 | 342.00M |
June 30, 2020 | 323.00M |
March 31, 2020 | 287.00M |
December 31, 2019 | 293.80M |
September 30, 2019 | 282.60M |
June 30, 2019 | 282.10M |
March 31, 2019 | 267.50M |
December 31, 2018 | 147.40M |
September 30, 2018 | 301.20M |
June 30, 2018 | 311.70M |
Date | Value |
---|---|
March 31, 2018 | 298.70M |
December 31, 2017 | 126.50M |
September 30, 2017 | 279.20M |
June 30, 2017 | 283.30M |
March 31, 2017 | 267.40M |
December 31, 2016 | 268.00M |
September 30, 2016 | 241.10M |
June 30, 2016 | 239.90M |
March 31, 2016 | 226.10M |
December 31, 2015 | 236.10M |
September 30, 2015 | 212.20M |
June 30, 2015 | 304.60M |
March 31, 2015 | 299.40M |
December 31, 2014 | -86.90M |
September 30, 2014 | 288.10M |
June 30, 2014 | 336.40M |
March 31, 2014 | 313.40M |
December 31, 2013 | 186.70M |
September 30, 2013 | 309.10M |
June 30, 2013 | 312.20M |
March 31, 2013 | 296.40M |
December 31, 2012 | 294.70M |
September 30, 2012 | 289.50M |
June 30, 2012 | 283.60M |
March 31, 2012 | 270.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
236.00M
Minimum
Dec 2022
441.00M
Maximum
Sep 2021
354.97M
Average
370.50M
Median
Research and Development Expense (Quarterly) Benchmarks
Quest Diagnostics Inc | -- |
Exact Sciences Corp | 120.88M |
Illumina Inc | 325.00M |
Natera Inc | 89.11M |
Castle Biosciences Inc | 14.14M |